Repeated courses of certain antibiotics associated with increased diabetes risk
the ONA take:
Repeated use of penicillins, cephalosporins, quinolones, and macrolides may increase people's risk of developing type 2 diabetes by changing their gut flora, a recent study published in the European Journal of Endocrinology has shown.
Researchers from the Departments of Gastroenterology and Medical Oncology at the University of Pennsylvania in Philadelphia, Pennsylvania, analyzed data from over 200,000 diabetics in the UK prescribed antibiotics in the years before diagnosis and compared the number of antibiotic prescriptions to the number prescribed to 800,000 non-diabetics.
Results showed that patients who were prescribed at least two courses of penicillins, cephalosporins, quinolones, and macrolides were at an increased risk of being diagnosed with type 2 diabetes.
Researchers also found that the risk increased with repeated antibiotic courses. The researchers suggest that the association between antibiotic use and diabetes may be due to antibiotics altering the diversity of gut bacteria.
Researchers found no that suggests anti-virals or anti-fungals increase the risk of type 2 diabetes and minimal evidence to support a link between antibiotics and an increased risk of type 1 diabetes.
The findings emphasize the necessity to decrease the number of unnecessary antibiotic prescriptions.
Repeated use of antibiotics may increase people's risk of developing type 2 diabetes by changing their gut flora.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|